Completed PHASE4 INTERVENTIONAL 4-arm NCT02935322

Interaction Between Chlorhexidine and Fluoride

Interaction Chlorhexidine-fluoride - a 4-day and 6-week Randomised Clinical Mouthrinse Study

Sponsor: Göteborg University

Conditions Dental Caries Periodontal Disease

Interventions 0.12 % chlorhexidine + 0.2 % NaF mouthrinse 0.12% chlorhexidine 0.2 % NaF mouthrinse Placebo

Updated 5 times since 2017 Last updated: Oct 12, 2016 Started: Sep 30, 2009 Primary completion: Dec 31, 2011 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02935322, this PHASE4 trial focuses on Dental Caries and Periodontal Disease and remains completed. Sponsored by Göteborg University, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Göteborg University
University of Oslo

Data source: University of Oslo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.